In subsequent experiments, SK-Hep1 cells, which do not express PCK1 and G6PC under normal conditions, were selected because we wanted to examine the anti-tumor effects of induced gluconeogenesis in HCC. This evidence concerns the gene PCK1 and hepatocellular carcinoma.